Singular Health Group's (ASX:SHG) Thomas Hanly tells Proactive's Andrew Scott its platform converts 2D MRI and CT scans into 3D and virtual reality. The company began trading on the ASX last week after successfully raising $6 million. He says the software is being used by surgeons in Australia and Switzerland with sales also coming out of South Africa and Singapore. Hanly adds that the beauty of the platform is that its vendor-neutral. ''We are developing software that is not only used by clinicians but also by patients'', he says.
Singular Health CEO says scalability of its unique medtech platform is key to growth
